Literature DB >> 31213541

Outflanking immunodominance to target subdominant broadly neutralizing epitopes.

Davide Angeletti1,2, Ivan Kosik3, Jefferson J S Santos3, William T Yewdell4, Carolyn M Boudreau5,6, Vamsee V A Mallajosyula7, Madeleine C Mankowski3, Michael Chambers8, Madhu Prabhakaran8, Heather D Hickman9, Adrian B McDermott8, Galit Alter5, Jayanta Chaudhuri4, Jonathan W Yewdell1.   

Abstract

A major obstacle to vaccination against antigenically variable viruses is skewing of antibody responses to variable immunodominant epitopes. For influenza virus hemagglutinin (HA), the immunodominance of the variable head impairs responses to the highly conserved stem. Here, we show that head immunodominance depends on the physical attachment of head to stem. Stem immunogenicity is enhanced by immunizing with stem-only constructs or by increasing local HA concentration in the draining lymph node. Surprisingly, coimmunization of full-length HA and stem alters stem-antibody class switching. Our findings delineate strategies for overcoming immunodominance, with important implications for human vaccination.

Entities:  

Keywords:  B cell; antibodies; hemagglutinin; immunodominance; influenza

Year:  2019        PMID: 31213541      PMCID: PMC6612916          DOI: 10.1073/pnas.1816300116

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  33 in total

Review 1.  Germinal centers.

Authors:  Gabriel D Victora; Michel C Nussenzweig
Journal:  Annu Rev Immunol       Date:  2012-01-03       Impact factor: 28.527

2.  Germinal center dynamics revealed by multiphoton microscopy with a photoactivatable fluorescent reporter.

Authors:  Gabriel D Victora; Tanja A Schwickert; David R Fooksman; Alice O Kamphorst; Michael Meyer-Hermann; Michael L Dustin; Michel C Nussenzweig
Journal:  Cell       Date:  2010-11-12       Impact factor: 41.582

3.  The receptor PD-1 controls follicular regulatory T cells in the lymph nodes and blood.

Authors:  Peter T Sage; Loise M Francisco; Christopher V Carman; Arlene H Sharpe
Journal:  Nat Immunol       Date:  2012-12-16       Impact factor: 25.606

4.  Immune interference in the setting of same-day administration of two similar inactivated alphavirus vaccines: eastern equine and western equine encephalitis.

Authors:  Ronald B Reisler; Paul H Gibbs; Denise K Danner; Ellen F Boudreau
Journal:  Vaccine       Date:  2012-09-29       Impact factor: 3.641

5.  Flow cytometry reveals that H5N1 vaccination elicits cross-reactive stem-directed antibodies from multiple Ig heavy-chain lineages.

Authors:  James R R Whittle; Adam K Wheatley; Lan Wu; Daniel Lingwood; Masaru Kanekiyo; Steven S Ma; Sandeep R Narpala; Hadi M Yassine; Gregory M Frank; Jonathan W Yewdell; Julie E Ledgerwood; Chih-Jen Wei; Adrian B McDermott; Barney S Graham; Richard A Koup; Gary J Nabel
Journal:  J Virol       Date:  2014-02-05       Impact factor: 5.103

6.  Mutual interference on the immune response to yellow fever vaccine and a combined vaccine against measles, mumps and rubella.

Authors:  Juliana Romualdo Nascimento Silva; Luiz Antonio B Camacho; Marilda M Siqueira; Marcos de Silva Freire; Yvone P Castro; Maria de Lourdes S Maia; Anna Maya Y Yamamura; Reinaldo M Martins; Maria de Luz F Leal
Journal:  Vaccine       Date:  2011-06-02       Impact factor: 3.641

7.  Influenza hemagglutinin stem-fragment immunogen elicits broadly neutralizing antibodies and confers heterologous protection.

Authors:  Vamsee V A Mallajosyula; Michael Citron; Francesca Ferrara; Xianghan Lu; Cheryl Callahan; Gwendolyn J Heidecker; Siddhartha P Sarma; Jessica A Flynn; Nigel J Temperton; Xiaoping Liang; Raghavan Varadarajan
Journal:  Proc Natl Acad Sci U S A       Date:  2014-06-09       Impact factor: 11.205

8.  Guiding the immune response against influenza virus hemagglutinin toward the conserved stalk domain by hyperglycosylation of the globular head domain.

Authors:  Dirk Eggink; Peter H Goff; Peter Palese
Journal:  J Virol       Date:  2013-10-23       Impact factor: 5.103

9.  A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins.

Authors:  Davide Corti; Jarrod Voss; Steven J Gamblin; Giosiana Codoni; Annalisa Macagno; David Jarrossay; Sebastien G Vachieri; Debora Pinna; Andrea Minola; Fabrizia Vanzetta; Chiara Silacci; Blanca M Fernandez-Rodriguez; Gloria Agatic; Siro Bianchi; Isabella Giacchetto-Sasselli; Lesley Calder; Federica Sallusto; Patrick Collins; Lesley F Haire; Nigel Temperton; Johannes P M Langedijk; John J Skehel; Antonio Lanzavecchia
Journal:  Science       Date:  2011-07-28       Impact factor: 47.728

10.  Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection.

Authors:  Jens Wrammert; Dimitrios Koutsonanos; Gui-Mei Li; Srilatha Edupuganti; Jianhua Sui; Michael Morrissey; Megan McCausland; Ioanna Skountzou; Mady Hornig; W Ian Lipkin; Aneesh Mehta; Behzad Razavi; Carlos Del Rio; Nai-Ying Zheng; Jane-Hwei Lee; Min Huang; Zahida Ali; Kaval Kaur; Sarah Andrews; Rama Rao Amara; Youliang Wang; Suman Ranjan Das; Christopher David O'Donnell; Jon W Yewdell; Kanta Subbarao; Wayne A Marasco; Mark J Mulligan; Richard Compans; Rafi Ahmed; Patrick C Wilson
Journal:  J Exp Med       Date:  2011-01-10       Impact factor: 14.307

View more
  31 in total

Review 1.  Subdominance in Antibody Responses: Implications for Vaccine Development.

Authors:  Gunnar Lindahl
Journal:  Microbiol Mol Biol Rev       Date:  2020-11-25       Impact factor: 11.056

2.  Hemagglutinin head-specific responses dominate over stem-specific responses following prime boost with mismatched vaccines.

Authors:  Sinthujan Jegaskanda; Sarah F Andrews; Adam K Wheatley; Jonathan W Yewdell; Adrian B McDermott; Kanta Subbarao
Journal:  JCI Insight       Date:  2019-11-14

3.  Monoclonal Antibody Responses after Recombinant Hemagglutinin Vaccine versus Subunit Inactivated Influenza Virus Vaccine: a Comparative Study.

Authors:  Carole Henry; Anna-Karin E Palm; Henry A Utset; Min Huang; Irvin Y Ho; Nai-Ying Zheng; Theresa Fitzgerald; Karlynn E Neu; Yao-Qing Chen; Florian Krammer; John J Treanor; Andrea J Sant; David J Topham; Patrick C Wilson
Journal:  J Virol       Date:  2019-10-15       Impact factor: 5.103

4.  Allelic polymorphism controls autoreactivity and vaccine elicitation of human broadly neutralizing antibodies against influenza virus.

Authors:  Maya Sangesland; Alba Torrents de la Peña; Seyhan Boyoglu-Barnum; Larance Ronsard; Faez Amokrane Nait Mohamed; Thalia Bracamonte Moreno; Ralston M Barnes; Daniel Rohrer; Nils Lonberg; Musie Ghebremichael; Masaru Kanekiyo; Andrew Ward; Daniel Lingwood
Journal:  Immunity       Date:  2022-08-10       Impact factor: 43.474

5.  Antigen presentation dynamics shape the response to emergent variants like SARS-CoV-2 Omicron strain after multiple vaccinations with wild type strain.

Authors:  Leerang Yang; Matthew Van Beek; Zijun Wang; Frauke Muecksch; Marie Canis; Theodora Hatziioannou; Paul D Bieniasz; Michel C Nussenzweig; Arup K Chakraborty
Journal:  bioRxiv       Date:  2022-08-25

6.  Induction of broadly reactive influenza antibodies increases susceptibility to autoimmunity.

Authors:  Jocelyn G Labombarde; Meenu R Pillai; Marie Wehenkel; Chun-Yang Lin; Rachael Keating; Scott A Brown; Jeremy Chase Crawford; David C Brice; Ashley H Castellaw; Alexandra H Mandarano; Clifford S Guy; Juan R Mejia; Carlessia D Lewis; Ti-Cheng Chang; Christine M Oshansky; Sook-San Wong; Richard J Webby; Mei Yan; Quan-Zhen Li; Tony N Marion; Paul G Thomas; Maureen A McGargill
Journal:  Cell Rep       Date:  2022-03-08       Impact factor: 9.995

7.  High-Resolution Mapping of Human Norovirus Antigens via Genomic Phage Display Library Selections and Deep Sequencing.

Authors:  Wanzhi Huang; Victoria Soeung; David M Boragine; Liya Hu; B V Venkataram Prasad; Mary K Estes; Robert L Atmar; Timothy Palzkill
Journal:  J Virol       Date:  2020-12-09       Impact factor: 5.103

8.  An R848-Conjugated Influenza Virus Vaccine Elicits Robust Immunoglobulin G to Hemagglutinin Stem in a Newborn Nonhuman Primate Model.

Authors:  Elene A Clemens; Beth C Holbrook; Masaru Kanekiyo; Jonathan W Yewdell; Barney S Graham; Martha A Alexander-Miller
Journal:  J Infect Dis       Date:  2021-07-15       Impact factor: 5.226

9.  Influenza virus infection expands the breadth of antibody responses through IL-4 signalling in B cells.

Authors:  Kosuke Miyauchi; Yu Adachi; Keisuke Tonouchi; Taiki Yajima; Yasuyo Harada; Hidehiro Fukuyama; Senka Deno; Yoichiro Iwakura; Akihiko Yoshimura; Hideki Hasegawa; Katsuyuki Yugi; Shin-Ichiro Fujii; Osamu Ohara; Yoshimasa Takahashi; Masato Kubo
Journal:  Nat Commun       Date:  2021-06-18       Impact factor: 14.919

Review 10.  Factors in B cell competition and immunodominance.

Authors:  Robert K Abbott; Shane Crotty
Journal:  Immunol Rev       Date:  2020-06-01       Impact factor: 10.983

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.